Tess Burleson - Jan 20, 2022 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/ David J. Arthur, Attorney-in-Fact
Stock symbol
SLRX
Transactions as of
Jan 20, 2022
Transactions value $
$0
Form type
4
Date filed
1/21/2022, 03:07 PM
Next filing
Jun 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLRX Stock Option (right to buy) Award $0 +30K $0.00 30K Jan 20, 2022 Common Stock 30K $0.48 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.